Extremely effective chemo-radiotherapy by inducing immunogenic cell death and radio-triggered drug release under hypoxia alleviation.

Local hypoxia in solid malignancies often results in resistance to radiotherapy (RT) and chemotherapy (CT), which may be one of main reasons for their failure in clinical application. Especially oxygen is an essential element for enhancing DNA damage caused by ionizing radiation in radiotherapy. Here, two biomimetic oxygen delivery systems were designed by encapsulating hemoglobin (Hb) alone into a liposome (Hb-Lipo) or co-encapsulating Hb and doxorubicin (DOX) into a liposome (DOX-Hb-Lipo). Our data indicated that both Hb-Lipo and DOX-Hb-Lipo could effectively alleviate the hypoxia in tumors. We demonstrated that RT plus tumor-targeting delivery of oxygen mediated by Hb-Lipo could significantly overcome the tolerance of hypoxic cancer cells to RT, showing significantly enhanced cancer cells killing and tumor growth inhibition ability, mainly attributing to hypoxia alleviation and increased ROS production under RT in cancer cells. Furthermore, a melanoma model that was quite insensitive to both RT and CT was used to test the efficacy of chemo-radiotherapy combined with hypoxia alleviation. RT plus Hb-Lipo only caused a limited increase in antitumor activity. However, extremely strong tumor inhibition could be obtained by RT combined with DOX-Hb-Lipo-mediated CT, attributing to radio-triggered DOX release and an enhanced immunogenic cell death induced by RT under oxygen supplement. Our study provided a valuable reference for overcoming hypoxia-induced radioresistance and a useful therapeutic strategy for cancers that are extremely insensitive to chemo- or radiotherapy.

• Publication year

  2019

• Venue

  ACS Applied Materials and Interfaces

• Publication date

  2019-11-21

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1021/acsami.9b16837PMID 31751119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• O2 Economizer for Inhibiting Cell Respiration To Combat the Hypoxia Obstacle in Tumor Treatments.

  2019cited by this paper
• Molecular landmarks of tumor hypoxia across cancer types

  2019cited by this paper
• Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.

  2018cited by this paper
• Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy

  2018cited by this paper
• Suppress orthotopic colon cancer and its metastasis through exact targeting and highly selective drug release by a smart nanomicelle.

  2018cited by this paper
• Hypoxia-Targeting, Tumor Microenvironment Responsive Nanocluster Bomb for Radical-Enhanced Radiotherapy.

  2017cited by this paper
• Mimicking oxygen delivery and waste removal functions of blood☆

  2017cited by this paper
• Erythrocyte‐Membrane‐Enveloped Perfluorocarbon as Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer Radiotherapy

  2017cited by this paper
• TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy.

  2017cited by this paper
• Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy

  2017cited by this paper
• Overcoming photodynamic resistance and tumor targeting dual‐therapy mediated by indocyanine green conjugated gold nanospheres

  2017cited by this paper
• Molecular targeting of hypoxia in radiotherapy☆

  2017cited by this paper
• Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery☆

  2017cited by this paper
• Perfluorocarbon‐Loaded Hollow Bi2Se3 Nanoparticles for Timely Supply of Oxygen under Near‐Infrared Light to Enhance the Radiotherapy of Cancer

  2016cited by this paper
• Intelligent Albumin–MnO2 Nanoparticles as pH‐/H2O2‐Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy

  2016cited by this paper
• Design of Pluronic-Based Formulation for Enhanced Redaporfin-Photodynamic Therapy against Pigmented Melanoma.

  2016cited by this paper
• Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia.

  2016cited by this paper
• Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies.

  2016cited by this paper
• Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma

  2016cited by this paper
• Molecular Pathways: A Novel Approach to Targeting Hypoxia and Improving Radiotherapy Efficacy via Reduction in Oxygen Demand

  2015cited by this paper
• Dynamic oxygen challenge evaluated by NMR T1 and T2* – insights into tumor oxygenation

  2015cited by this paper
• Immunogenic cell death.

  2015cited by this paper
• Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience

  2014cited by this paper
• Capillary pericytes regulate cerebral blood flow in health and disease

  2014cited by this paper
• Immunogenic cell death in cancer therapy.

  2013cited by this paper
• Imaging hypoxia to improve radiotherapy outcome

  2012cited by this paper
• Highly loaded hemoglobin spheres as promising artificial oxygen carriers.

  2012cited by this paper
• Hyperbaric oxygen therapy and cancer—a review

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Cationic amylose-encapsulated bovine hemoglobin as a nanosized oxygen carrier.

  2011cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability

  2008cited by this paper
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008cited by this paper
• Drug resistance and the solid tumor microenvironment.

  2007cited by this paper
• Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions.

  2007cited by this paper
• Polymersome encapsulated hemoglobin: a novel type of oxygen carrier.

  2005cited by this paper
• Involvement of reactive oxygen species (ROS) in the induction of genetic instability by radiation.

  2004cited by this paper
• Exploiting tumour hypoxia in cancer treatment

  2004cited by this paper
• Relief of oxidative stress by ascorbic acid delays cellular senescence of normal human and Werner syndrome fibroblast cells.

  2003cited by this paper
• The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

  1953cited by this paper

• Research progress in construction of organic carrier drug delivery platform using tumor microenvironment

  2024cites this paper
• Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy

  2023cites this paper
• Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy

  2023cites this paper
• Promotion of ICD via Nanotechnology.

  2023cites this paper
• Recent Advances in Nanoplatform Construction Strategy for Alleviating Tumor Hypoxia

  2023cites this paper
• Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy

  2022cites this paper
• The strategy of precise targeting and in situ oxygenating for enhanced triple-negative breast cancer chemophototherapy.

  2022cites this paper
• Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma

  2022cites this paper
• Oxygen-generating materials and their biomedical applications: a review

  2022cites this paper
• Biomimetic nanomaterial-facilitated oxygen generation strategies for enhancing tumour treatment outcomes

  2022cites this paper
• Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection.

  2022cites this paper
• Research progress in inducing immunogenic cell death of tumor cells

  2022cites this paper
• Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment.

  2021cites this paper
• Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy.

  2021cites this paper
• Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: where do we stand?

  2021cites this paper
• An overview of the developments and potential applications of 68Ga-labelled PET/CT hypoxia imaging

  2021cites this paper
• Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance

  2021cites this paper
• Strategies of Alleviating Tumor Hypoxia and Enhancing Tumor Therapeutic Effect by Macromolecular Nanomaterials.

  2021cites this paper
• A clinically acceptable strategy for sensitizing anti-PD-1 treatment by hypoxia relief.

  2021cites this paper
• Tumor Microenvironment-Activated Nanoparticles Loaded with an Iron-Carbonyl Complex for Chemodynamic Immunotherapy of Lung Metastasis of Melanoma In Vivo.

  2021cites this paper
• Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF-1 pathway under nutrient-deprived conditions

  2020cites this paper
• Nanoenabled Tumor Oxygenation Strategies for Overcoming Hypoxia-Associated Immunosuppression.

  2020cites this paper
• Immunogenicity of Externally Activated Nanoparticles for Cancer Therapy

  2020cites this paper